Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.200 -0.090 (-1.24%)
Streaming Delayed Price Updated: 3:36 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
62 63 Next >
Novavax Gets Expanded Authorization From European Commission For COVID-19 Vaccine
The European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Novavax’s (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for... 
Via Benzinga
Why Is Novavax (NVAX) Stock Rallying Today?
Novavax (NVAX) stock is taking off on Tuesday after the vaccine company got approval for the expanded use of its Covid-19 vaccine in Europe. 
Via InvestorPlace
Why Is Novavax (NVAX) Stock Up 10% Today?
Interest around the potential for another Covid-19 surge this winter, as well as vaccine efficacy, has NVAX stock soaring today. 
Via InvestorPlace
Stock Market Rally Under Pressure; Micron, GM, Nike, RH Warn: Weekly Review
The major indexes sold off sharply. Micron and GM warned on earnings. 
Via Investor's Business Daily
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
The request is a boon for BioNTech and Moderna, both of which are facing a sales cliff. 
Via Investor's Business Daily
Highest Increases in Short Interest
A look at the 20 Russell 1000 stocks that have seen the largest increases in short interest as a percentage of float (SIPF) on a year-to-date basis. 
Via Talk Markets
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,... 
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax. 
Via InvestorPlace
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
As COVID-19 continues to mutate and form new variants, the FDA is calling on the major vaccine manufacturers to create a new composition of the vaccine for adults. 
Via Benzinga
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
A panel of experts will decide whether to recommend omicron-specific boosters. 
Via Investor's Business Daily
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Why Novavax Stock Is Up 11% Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Thursday after the company announced that its COVID-19 vaccine was recommended for an expanded conditional marketing authorization in the European... 
Via Benzinga
Airline Stocks Fall as American, United Continue to Cut Flights
Airline stocks are slipping on Thursday as companies are continuing to cut flights amid pilot shortages and other problems. 
Via InvestorPlace
Short Squeeze Hopes Take Weber (WEBR) Stock 13% Higher
Weber (WEBR) stock is on the move Thursday as retail traders push for a short squeeze of the American grill company's shares. 
Via InvestorPlace
Novavax (NVAX) Stock Gains 7% on EMA Recommendations
Novavax (NVAX) stock is gaining Thursday on news of a recommendation for the vaccine company's Covid-19 shot for teens in Europe. 
Via InvestorPlace
NOVAVAX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Novavax, Inc. - NVAX
From Kahn Swick & Foti, LLC
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Novavax Stock Can Rally, But It’s Still Facing Many Obstacles
Novavax's vaccine will likely be approved by the FDA relatively soon, but NVAX stock is still facing many obstacles. 
Via InvestorPlace
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Here's why its protein-based shot could struggle in the U.S. 
Via Investor's Business Daily
5 Biotech Stocks To Watch During The Week Of June 13
Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a... 
Via Benzinga
Stock Market Rally Under Pressure As Indexes Tumble, Breakouts Fail: Weekly Review
The 10-year Treasury yield soared above 3% as inflation came in hot. 
Via Investor's Business Daily
What You Missed On Wall Street On Thursday
Here are our top five lists with the news and calls moving stocks, that you better not have missed yesterday... 
Via Talk Markets
Why Moderna Stock Is Moving Lower Today
Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday as vaccine stocks fall in sympathy with Novavax Inc (NASDAQ: NVAX) following reports the FDA's decision on the company's COVID-19 vacci 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
69 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday. 
Via Benzinga
Novavax Stock Skids As FDA Leaves Its Covid Vaccine Decision Hanging
Two days after advisors recommended the shot, the FDA has yet to make a move. 
Via Investor's Business Daily
Why Novavax Stock Is Falling Today
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following reports that the U.S. Food and Drug Administration's decision on the company's COVID-19 vaccine could be delayed to review... 
Via Benzinga
HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated
HC Wainwright says safety concerns were noted for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, but the strength of data showed that benefit outweighs risks. 
Via Benzinga
Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
Novavax, Inc (NASDAQ: NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat. 
Via Benzinga
Why This Novavax Analyst Remains Bearish After COVID Vaccine Panel Vote
A Bank of America analyst remains bearish on Novavax, Inc (NASDAQ: NVAX) after a regulatory panel approved Novavax’s Emergency Use Authorization request fo 
Via Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.